Combination of abiraterone and cabazitaxel in metastatic castration-resistant prostate cancer

Optimizing survival in advanced prostate cancer: Tailoring mCRPC therapies to optimise survival

Optimizing Survival in Advanced Prostate Cancer: Conclusion

Cancer cell models for improved therapies

Biobanking biological materials and linkage to clinical information

EU privacy regulations could have negative impact on the fight against cancer

The future of e-learning technology in continuing medical education

Virtual patient simulation: an innovation in e-learning technology

Implementing CME policy that is right for Europe

Combination therapy for high-risk MDS? Not quite yet

ASH 2014: Highlights in mantle cell lymphoma

ASH 2014: Highlights in multiple myeloma